S O M A T E C

About Us

SOMATEC PHARMACEUTICALS LTD. is a fast growing pharmaceutical company in Bangladesh.

Contact Info

28/B, Segun Bagicha, Dhaka-1000, Bangladesh.

+880-02-9337667

+880-02-9357827

+880-02-8391480

info@somatecpharmabd.com

Neoprox

Cefpodoxime Proxetil is an orally administered extended spectrum, semi-synthetic 3rd generation antibiotic of cephalosporin class. Like other b-lactam antibiotics it is a bactericidal drug that acts by inhibition of bacterial cell wall synthesis.

Brand Name

: Neoprox

Generic Name

: Cefpodoxime Proxetil

Therapeutic Class

: Antibiotics

Strength

:
15ml 50ml

Indications

Neoprox (Cefpodoxime Proxetil) is indicated for the treatment of patients infected with susceptible strains of microorganisms, which include a wide range of gram-positive & gram-negative bacteria. As it is highly stable in presence of b-lactamase enzyme, it is more effective against gram-positive bacteria than other 3rd generation oral Cephalosporins.
Neoprox (Cefpodoxime Proxetil) is indicated in the following diseases: -
1. Lower respiratory tract infections: Acute community-acquired pneumonia, acute
   bacterial exacerbation of chronic bronchitis.
2. Upper respiratory tract infections: Acute otitis media, acute maxillary sinusitis,
   pharyngitis, tonsillitis.
3. Sexually transmitted diseases: Acute uncomplicated urethral & cervical
   gonorrhea, acute ano-rectal infection in woman caused by N. gonorrhea.
4. Uncomplicated urinary tract infections: Cystitis, pyuria.
5. Skin & soft tissue infections: Furuncle, cellulitis, subcutaneous abscess,
   Infectious atheroma & periproctal abscess.

Dosage

Children:
15 days - 6 months:  4 mg/kg every 12 hours
6 months - 2 years :  40 mg every 12 hours
3 - 8 years :  80 mg every 12 hours 
Over 9 years :  100 mg every 12 hours

Patients with liver cirrhosis: Cefpodoxime proextil's pharmacokinetics in cirrhotic patients is similar to those in healthy subjects. Dose adjustment is not necessary in this population. 

Interaction

Antacids: Concomitant administrations of high doses of antacids (sodium bicarbonate and aluminum hydroxide) or H2 -blockers reduces plasma level by 24% to 42% and the extent of absorption by 27% to 32% respectively. 
Probenecid: Renal excretion of Cefpodoxime was inhibited by probenecid and resulted in an approximately 31% increase in AUC. 
Nephrotoxic drugs: Close monitoring of renal function advised when Cefpodoxime proxetil is administered concomitantly with compounds of known nephrotoxic potential.

Contraindications

Cefpodoxime proxetil is contraindicated in patients with a known allergy to Cefpodoxime or to the cephalosporin group of antibiotics.

Side Effects

Cefpodoxime has very few side effects. The side effects include diarrhoea, nausea, skin & vaginal fungal infection, abdominal pain, headache, chest pain, myalgia, dyspepsia, dizziness, vertigo, cough etc. In children, incidence of fungal skin rash is more than adults.

Pregnancy & Lactation

Cefpodoxime was neither teratogenic nor embryocidal in animal trial. There is, however, no adequate and well-controlled study of cefpodoxime proxetil in pregnant woman. The drug should be used during pregnancy only if clearly needed.

Precautions & Warnings

In patients with transient or persistent reduction in urinary output due to renal insufficiency, the total daily dose of cefpodoxime proxetil should be reduced. As with other broad-spectrum antibiotics, prolonged use of cefpodoxime proxetil may result in overgrowth of non-susceptible organisms. Repeated evaluation of the patient's condition is essential. 

Overdose Effects

Overdosage may cause toxic reaction. Toxic symptoms include nausea, vomiting, epigastric distress and diarrhea.

Indications

Neoprox (Cefpodoxime Proxetil) is indicated for the treatment of patients infected with susceptible strains of microorganisms, which include a wide range of gram-positive & gram-negative bacteria. As it is highly stable in presence of b-lactamase enzyme, it is more effective against gram-positive bacteria than other 3rd generation oral Cephalosporins.
Neoprox (Cefpodoxime Proxetil) is indicated in the following diseases: -
1. Lower respiratory tract infections: Acute community-acquired pneumonia, acute
   bacterial exacerbation of chronic bronchitis.
2. Upper respiratory tract infections: Acute otitis media, acute maxillary sinusitis,
   pharyngitis, tonsillitis.
3. Sexually transmitted diseases: Acute uncomplicated urethral & cervical
   gonorrhea, acute ano-rectal infection in woman caused by N. gonorrhea.
4. Uncomplicated urinary tract infections: Cystitis, pyuria.
5. Skin & soft tissue infections: Furuncle, cellulitis, subcutaneous abscess,
   Infectious atheroma & periproctal abscess.

Dosage

Children:
15 days - 6 months:  4 mg/kg every 12 hours
6 months - 2 years :  40 mg every 12 hours
3 - 8 years :  80 mg every 12 hours 
Over 9 years :  100 mg every 12 hours

Patients with liver cirrhosis: Cefpodoxime proextil's pharmacokinetics in cirrhotic patients is similar to those in healthy subjects. Dose adjustment is not necessary in this population. 

Interaction

Antacids: Concomitant administrations of high doses of antacids (sodium bicarbonate and aluminum hydroxide) or H2 -blockers reduces plasma level by 24% to 42% and the extent of absorption by 27% to 32% respectively. 
Probenecid: Renal excretion of Cefpodoxime was inhibited by probenecid and resulted in an approximately 31% increase in AUC. 
Nephrotoxic drugs: Close monitoring of renal function advised when Cefpodoxime proxetil is administered concomitantly with compounds of known nephrotoxic potential.

Contraindications

Cefpodoxime proxetil is contraindicated in patients with a known allergy to Cefpodoxime or to the cephalosporin group of antibiotics.

Side Effects

Cefpodoxime has very few side effects. The side effects include diarrhoea, nausea, skin & vaginal fungal infection, abdominal pain, headache, chest pain, myalgia, dyspepsia, dizziness, vertigo, cough etc. In children, incidence of fungal skin rash is more than adults.

Pregnancy & Lactation

Cefpodoxime was neither teratogenic nor embryocidal in animal trial. There is, however, no adequate and well-controlled study of cefpodoxime proxetil in pregnant woman. The drug should be used during pregnancy only if clearly needed.

Precautions & Warnings

In patients with transient or persistent reduction in urinary output due to renal insufficiency, the total daily dose of cefpodoxime proxetil should be reduced. As with other broad-spectrum antibiotics, prolonged use of cefpodoxime proxetil may result in overgrowth of non-susceptible organisms. Repeated evaluation of the patient's condition is essential. 

Overdose Effects

Overdosage may cause toxic reaction. Toxic symptoms include nausea, vomiting, epigastric distress and diarrhea.

Related Product.

A-product

RESPAZIT

Azithromycin

More Info
A-product

Clindamet

Clindamycin Hydrochloride

More Info
A-product

Levora

Levofloxacin

More Info
A-product

Tyflox

Ciprofloxacin

More Info